Synonyms: Anti-BRG1-associated factor 57; Anti-SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 is a protein encoded by the SMARCE1 gene in humans. It is also referred to as BAF57. It is a component of the switching-defective and sucrose nonfermenting (SWI/SNF) chromatin-remodeling complex conglomerate that modulates androgen receptor activity to promote prostate cancer. It is involved in chromatin remodeling and is associated with pathogenesis of both meningiomas and tumors with clear-cell histology. Its activity may be one of the candidates for endometrial cancer therapy, especially therapy for aggressive tumors showing overexpression of p53. Mutation in this gene causes spinal clear cell meningiomas.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC